Retinal Ischemic Perivascular Lesions Are Associated with Cardiovascular Diseases in Patients with Severe Carotid Artery Stenosis

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Background/Objectives: The objective of this study is to evaluate the association between retinal ischemic perivascular lesions (RIPLs) and cardiovascular diseases (CVDs) among patients diagnosed with severe carotid artery stenosis (SCAS). Methods: Consecutive patients (123 patients) with SCAS were included and underwent swept-source optical coherence tomography angiography (SS-OCTA). Retinal structural and blood flow parameters of the macular region were calculated and compared between patients with and without CVD. The prevalence of RIPLs confirmed on B-scan images was compared between patients with and without CVD. The relationship between RIPLs and CVD in patients with SCAS was explored using multivariate logistic regression analysis. Subgroup analysis was conducted to evaluate the relationship between ipsilateral RIPLs, contralateral RIPLs, and bilateral RIPLs and CVD. Results: Of the 123 patients with SCAS, 61 patients (49.6%) had a history of CVD. The CVD group had lower vessel density in the superficial and deep retinal vascular complexes, thinner inner retinal thickness, and thicker outer retinal thickness compared with the non-CVD group. A higher prevalence of RIPLs was found in the CVD group compared to the non-CVD group (55.7% vs. 30.6%, p = 0.006). The presence of RIPLs was significantly associated with CVD in SCAS patients (OR = 3.953 [1.695–9.219], p = 0.001) after adjusting for covariates. Subgroup analysis revealed greatest risk of bilateral RIPLs for CVD (OR = 7.383 [1.749–30.393], p = 0.006), followed by contralateral RIPLs (OR = 4.024 [1.432–11.306], p = 0.008) and ipsilateral RIPLs (OR = 2.951 [1.258–6.921], p = 0.013). Conclusions: The presence of RIPLs is significantly associated with CVD in SCAS patients. Findings of this research demonstrated that evaluation of RIPLs may help identify high-risk SCAS patients and facilitate special medical care for this group of patients.
Funding Information
  • Chengdu Municipal Science and Technology Bureau Key R&D Support Program (2023-YF09-00041-SN)

This publication has 25 references indexed in Scilit: